Weekly round-up #94

Teamwork Problem Solving

Weekly round-up #94

We've had a number of new Associate members joining this week, so welcome to:

  • Obondo James Sande (Makerere University College of Health Sciences, Uganda)
  • Mostafa Anower (Patuakhali Science and Technology University, Bangladesh)
  • Supram Hosuru Subramanya (Manipal College of Medical Sciences, India)
  • Susanna Brighenti (Karolinska Institutet, Sweden)
  • Gabriele Pollara (UCL, UK)
  • Marisa Klopper (Stellenbosch University, South Africa)
  • Liezel Smith (Stellenbosch University, South Africa)
  • Iqbal Elyazar (Eijkman-Oxford Clinical Research Unit, Indonesia)
  • Onrapak Reamtong (Mahidol University, Thailand)

 

It's been a quiet week for new items. You can find all relevant funding opportunities on our external funding page, visit our training opportunities page for further ideas to develop your career, and see our events page for all events coming up in our field.

 

Job Opportunities: 

All previously spotted vacancies are listed on our job webpage.

Publications:

Our publications page highlights papers of interest by our members and in the fields of our focus pathogens. If you publish a relevant paper, let us know so that we can highlight it to our members.

 

Highlights on Twitter this week: a £170 million investment in bioscience from BBSRC will fund 1700 PhD researchers over 5 annual cohorts; more coverage of the Daily Mail UK Campaign to reverse the decline of vaccine uptake; a new triage test for TB that spots infections within an hour; advice for PhD students on how to write a great science paper & please editors, readers & yourself; Nature has created a 'careers toolkit' for ECRs; Dr Elisa Nemes gives an overview of the current state of TB vaccines; Shobha Shukla shares insights from doctors on how TB prevention may be better than a cure; reports of an increase in new tuberculosis and leprosy cases in India; Christopher Elias discusses the approach and strategy of the Bill and Melinda Gates Foundation on vaccine preventable diseases; and of course lots of coverage of the NEJM M72/AS01E final analysis. Follow us @NetworkVALIDATE to easily stay up to date.

 

Published: 30 October 2019